The variable clinical course of peripartum cardiomyopathy

Biomedical Papers

Volumn 158, Issue 1, 2014, Pages 92-97

  Krejci, Jan ^a   Hude, Petr ^a   Spinarova, Lenka ^a   Zampachova, Vita ^a   Sirotkova, Alzbeta ^a   Freiberger, Tomas ^b   Nemcova, Eva ^b   Vitovec, Jiri ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

Author keywords

Echocardiography; Endomyocardial biopsy; Myocarditis; Peripartum cardiomyopathy; Therapy

Indexed keywords

ADULT; CASE REPORT; COMPLICATION; DEATH, SUDDEN, CARDIAC; DYSPNEA; FATALITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MYOCARDITIS; PERINATAL PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; YOUNG ADULT;

ADULT; DEATH, SUDDEN, CARDIAC; DYSPNEA; FATAL OUTCOME; FEMALE; HEART FAILURE; HUMANS; MYOCARDITIS; PERIPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84897411885     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2012.080     Document Type: Article

References (26)

1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Waktins H, Shah A, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JV. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-78.
2. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-8.
3. Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: Causes, diagnosis, and treatment. Cleve Clin J Med 2009;76(5):289-96.
4. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.
5. Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. AfricanAmerican women have a higher risk for developing peripartum cardiomyopathy. J Am Coll Cardiol 2010;55:654-9.
6. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-6.
7. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young GB. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006;113:1807-16.
8. Van Spaendonck-Zwarts KY, Van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JDH, Paulus WJ, Dooijes D, van den Berg M. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169-75.
9. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States. Diagnosis, prognosis, and management. J Am Coll Cardiol 2011;58:659-70.
10. Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: A comprehensive review. Int J Cardiol 2007;118:295-303.
11. Nabhan A. Peripartum cardiomyopathy. ASJOG 2005;2:231-7.
12. Schultheiss HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J 2011;32:2616-25.
13. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kühl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007;116:2216-33.
14. Narula N, McNamara DM. Endomyocardial biopsy and natural history of myocarditis. Heart Fail Clin 2005;1:391-406.
15. Cooper LT, Mather PJ, Alexis JD, Pauly DF, Torre-Amione G, Wittstein IS, Dec GW, Zucker M, Narula J, Kip K, McNamara DM. Myocardial Recovery in Peripartum Cardiomyopathy: Prospective Comparison With Recent Onset Cardiomyopathy in Men and Nonperipartum Women. J Cardiac Fail 2012;18:28-33.
16. Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2007;118:14-20.
17. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363-5.
18. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8.
19. Melvin K, Richardson P, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982;307:731-4.
20. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104:39-45.
21. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-2002.
22. Hilfiker-Kleiner D, Sliwa K, Drexler H. Peripartum cardiomyopathy: Recent insights in its pathophysiology. Trends Cardiovasc Med 2008;18:173-9.
23. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, labidi S, Struman I, Hilfiker-Kleiner D. Evaluation of bromocriptin in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010;121:1465-73.
24. Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P. The addition of pentoxiphylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Hear Fail 2002;4:305-9.
25. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.
26. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Hameed A, Gviazda I, Shotan A. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.